The 60th Annual Meeting of the
Scandinavian Society for the Study of Diabetes
Keynote speakers and Bio
Olov Andersson
Olov Andersson studied pharmacy at Uppsala university, then performed a PhD at Karolinska Institutet regarding TGF-β signaling in development and metabolism using the mouse model. For his postdoctoral work he moved to the lab of Didier Stainier at UCSF and studied the pancreas using the zebrafish model. He set up an independent laboratory at the Karolinska Institutet in 2012 and moved to Uppsala University in 2024, where he is now Professor of Experimental Diabetes Research. Bridging drug discovery, metabolism and β-cell regeneration, his lab screens in the zebrafish model and translate findings to mice and human samples. He has received several awards, among them the ERC consolidator award and the Leif C. Groop award for outstanding diabetes research.
Tore Bengtsson
Tore Bengtsson, PhD, is Professor of Physiology at Stockholm University. His research focuses on metabolism, obesity, and type 2 diabetes, with a particular emphasis on translational physiology and clinically relevant approaches to metabolic disease. His work bridges mechanistic biology and applications relevant to human metabolic health.
Amélie Bonnefond
Bio coming soon.
Per-Ola Carlsson
Bio coming soon.
Elaine Yee Kwan Chow
Elaine Chow received her medical training in UK and completed her PhD at the University of Sheffield in 2015. She since joined the Chinese University of Hong Kong, where she helped set up glucose clamp and continuous glucose monitoring (CGM) studies at the Phase 1 Clinical Trial Centre. In 2022, she received the Women’s Interprofessional Network of the American Diabetes Association abstract award on her work showing dorzagliatin, a dual-acting glucokinase activator increases insulin secretion in beta cell glucose sensitivity in GCK-MODY and recent onset type 2 diabetes. She was awarded the Hong Kong College Physicians Richard Yu Lecture in 2022 and Sir David Todd Lecture in 2024. She is Associate Editor for Diabetes Research and Clinical Practice and editorial board member for several journals.
Ulf Eriksson
Senior Professor at Karolinska Institutet (2025–present); Professor of Vascular Biochemistry at Karolinska Institutet (2010–2025); Assistant/Associate/Full Member at the Ludwig Institute for Cancer Research, Stockholm Branch (1988–2009); Council Professor at the Swedish Research Council (Vetenskapsrådet) (2018–2027); Member of the Nobel Assembly at Karolinska Institutet (2012–2024) and its Chair in 2022; Member of the Nobel Committee in 2022; various positions of trust at Karolinska Institutet (2018–2025); Chair of the Board of Comparative Medicine at Karolinska Institutet (2018–2025); Member of the Central Animal Ethics Committee (CDFN) (2022–present).
Jarl Hellman
Senior consultant and clinical researcher in diabetes at Uppsala University Hospital.
Head of Diabetes care in adults and coordinator for the Centre of excellence Type 1 diabetes at Uppsala University Hospital.
Excellent Teacher and Program Director for the Medicine Program at Uppsala University and course leader at the Department of Medical Sciences
President of the Swedish Society for Diabetology since 2024, the “Diabetologist of the Year in Sweden 2017”.
Research activities mostly focused of implementing new diabetes technology (insulin pumps and continuous glucose monitoring, CGM) and modern treatment methods in clinical practice.
Martin Heni
Professor Martin Heni is a physician-scientist in endocrinology and diabetology at the University of Ulm (Germany), where he leads research on brain insulin resistance and its role in the heterogeneity and pathophysiology of type 2 diabetes and unhealthy obesity. His work further addresses body fat distribution and sex-specific mechanisms, integrating clinical studies with advanced phenotyping and omics approaches to investigate underlying mechanisms and translate these insights into the clinical setting. He has received multiple awards, including the EASD’s Minkowski Prize and an ERC Consolidator Grant, and contributes to collaborative research initiatives in the field.
Jens Juul Holst
Jens Juul Holst is Professor of Medical Physiology at the Department of Biomedical Sciences, University of Copenhagen. He is also Senior Group Leader at the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen.
Professor Holst’s scientific work has focused on the regulatory peptides of the pancreas and the gut and their importance in the regulation of the functions of the GI-tract and metabolism. Professor Holst great scientific achievements include the discovery of GLP-1 (glucagon-like peptide 1) a gut hormone regulating insulin secretion and appetite and food intake and his subsequent basic and translational research in this field.
Fredrik Karpe
Fredrik Karpe is a physician-scientist who is professor of metabolic medicine at the University of Oxford He leads the Lipid Clinic Service in at the university hospital in Oxford and has a special interest in lipodystrofies.
His main research is in obesity and regulation of human fat distribution in relation to health and disease. He is using genomic and physiological tools to investigate metabolic consequences of dysfunctional metabolism in relation of adipose tissue function.
Mikael Knip
Bio coming soon.
Olle Korsgren
Dr Korsgren has served as Senior Consultant at the Department of Clinical Immunology and Transfusion Medicine since 2001. He was appointed Professor of Transplantation Immunology in 2002 and obtained a tenured faculty position as Professor of Cell Transplantation in 2006. He is the founder and principal investigator of the Nordic Network for clinical islet transplantation.
Dr. Korsgren’s research activity has been focused on elucidating the etiology of Type 1 Diabetes, PET-imaging, Immuno-Oncology and to make islet transplantation without the need for systemic immunosuppression a possible treatment for patients with Type 1 Diabetes. Dr. Korsgren has authored more than 400 scientific publications.
Patrik Rorsman
Patrik Rorsman is Professor of Diabetic Medicine (statutory) and Professorial Fellow of Harris Manchester College, University of Oxford.
Patrik Rorsman obtained in PhD at the University of Uppsala in1986. He then moved to the University of Göteborg (Sweden). In 1994 he became Director of Islet Research at Novo Nordisk in Copenhagen. He returned to academia in 1997 when he became Professor of Membrane Physiology at Lund University, where he remained until 2003 when he was elected Professor of Diabetic Medicine at the University of Oxford. Since 2013 he also directs the Metabolic Physiology unit at the University of Göteborg. He is a Member of Academia Europea (since 2006), a Fellow of the Academy of Medical Science (FMedSci; since 2010) and a Fellow of the Royal Society (FRS; since 2014).
Patrik’s research focuses on the cellular control of pancreatic hormone secretion, how these processes become impaired in diabetes and their – possible – correction by therapeutic interventions.
Peter Rossing
Peter Rossing is a clinician researcher devoted to complications in diabetes with focus on renal and cardiovascular complications. He obtained a specialist degree in internal medicine and endocrinology 2004. Since 2007 he has been a chief physician and manager of the Steno Diabetes Center Copenhagen research team dedicated to the research of micro-and macrovascular complications of diabetes.
Since 2012 Professor in diabetic angiopathy at University of Copenhagen. Peter Rossing has in epidemiological studies investigated key features of the pathophysiology of the diabetic kidney at different stages. He has identified several markers for development of diabetic nephropathy; making it possible to predict the individual risk. He has been involved in several intervention studies in patients with overt diabetic nephropathy aiming at improving the prognosis including DAPA-CKD, FIGARO-DKD, FIDELIO-DKD and FLOW.
He received the Minkowski prize in 2005 and the Golgi prize in 2016 both from the EASD and the E. Bierman award from ADA and the Hormon Medal from European Society of Endocrinology. Past president of the Danish Endocrine Society, and of the European Diabetic Nephropathy Study group and chairman of the Danish National Diabetes Registry and the Independent Research Fund Denmark-Health and Disease.
Harriet Wallberg
Harriet Wallberg, MD, is a professor of physiology at Karolinska Institute and has had a long career in medical research and academic leadership. Her research has primarily focused on metabolism, diabetes, and lifestyle factors affect health. In recent years, her work has been directed toward how circadian rhythms influence blood glucose regulation in people with type 2 diabetes, with a particular focus on time-of-day effects of exercise. Harriet Wallberg has published many groundbreaking scientific papers and been a member of the Nobel Assembly at Karolinska Institute. She has received numerous scientific awards and honorary doctorates from international universities.
Contact us
Conference Secretariat: Academic Conferences
Email: SSSD2026@akademikonferens.se
Phone: + 46 18 67 12 28 or +46 18 67 10 03
Important dates
28 January - Abstract submission opens
31 March - Abstract submission deadline
Mid-April - Abstract notification
30 April - Early bird deadline
21-23 May – Conference dates
